期刊文献+

表皮生长因子、转化生长因子-α及其受体在人垂体腺瘤组织中的表达 被引量:3

Expressions of EGF,TGF-α and EGFR mRNAs in the pituitary adenoma tissues
原文传递
导出
摘要 目的探讨表皮生长因子 (EGF)、转化生长因子 α(TGF α)和表皮生长因子受体 (EGFR)在垂体腺瘤发生、发展过程中的作用。方法应用放射性原位分子杂交法 ,观察上述3种分子的表达。结果在检测的22例垂体腺瘤组织中 ,分别有17例 (77 % )、12例(55 %)和20例(91 %)显示有EGF ,TGF α和EGFRmRNA的过度表达 ,它们在正常垂体组织中的阳性率分别为42 % ,25 %和42 %。不同的垂体腺瘤组织中3种mRNA的表达强度有差异。结论垂体腺瘤中存在着EGF/EGFR或/和TGF α/EGFR自分泌系统 ,该系统在垂体腺瘤的分化及增殖过程中可能起着重要的作用。 Aim To investigate the roles of epidermal growth factor(EGF), transforming growth factor α(TGF α) and EGF receptor(EGFR) in the occurrence and development of pituitary adenoma. Methods Expressions of the above three molecules were observed by radioactive in situ hybridization technique. Results Among the tissues of 22 pituitary adenoma, 17(77%),12(55%) and 20(91%)of them exhibited high expressions of EGF, TGF αand EGFR mRNAs, respectively. The positive rate of three molecules in normal pituitary tissues were 42%, 25%and 42%, respectively. The expression intensities of three molecules were different in different pituitary adenoma tissues. Conclusion The autocrine system of EGF/EGFR and/or TGF α/EGFR may be existing in the pituitary adenoma. It may play an important role in the proliferation and differntiation of pituitary adenoma.
出处 《细胞与分子免疫学杂志》 CSCD 2000年第2期156-158,共3页 Chinese Journal of Cellular and Molecular Immunology
关键词 垂体腺瘤 表皮生长因子 转化生长因子Α pituitary adenoma EGF TGF α EGFR in situ hybridization
  • 相关文献

参考文献1

二级参考文献2

  • 1Paul W. Brandt-Kauf,Regina Monaco,Matthew R. Pincus. Conformation of the transmembrane domain of the epidermal growth factor receptor[J] 1994,Journal of Protein Chemistry(2):227~231
  • 2Mayumi Naramura,Stephen D. Gillies,John Mendelsohn,Ralph A. Reisfeld,Barbara M. Mueller. Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma[J] 1993,Cancer Immunology Immunotherapy(5):343~349

共引文献6

同被引文献23

  • 1黄平.表皮生长因子与肿瘤[J].生理科学进展,1989,20(1):22-22.
  • 2陈泽霖 戴豪良 等.1046例肿瘤患者舌象观察[J].中西医结合杂志,1981,1(2):81-83.
  • 3[1]Bloomer CW, Kenyon L, Hammond E, et al. Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor(EGFR) expression in human pituitary macroadenomas [J].Am J Clin Oncol, 2003; 26(4 Suppl): 75-80.
  • 4[2]LeRiche VK, Asa SL, Ezzat S. Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness [J]. J Clin Endocrinol Metab, 1996; 81(2): 656-662.
  • 5[3]Klibanski A. Nonsecreting pituitary tumors [J]. Endocrinol Metab Clin North Am, 1987, 16(3): 793-804.
  • 6[4]Chaidarun SS, Eggo MC, Sheppard MC, et al. Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro [J]. Endocrinology, 1994; 135(5): 2012-2021.
  • 7[7]Sugawa N, Ekstrand A J, James CD, et al. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas [J]. Proc Natl Acad Sci USA, 1990; 87(21): 8602-8606.
  • 8[8]Wong AJ, Ruppert JM, Bigner SH, et al. Structural alterations of the epidermal growth factor receptor gene in human gliomas [J]. Proc Natl Acad Sci USA, 1992; 89(7): 2965-2969.
  • 9[9]Finley EL, Ramsdell JS. A transforming growth factor-alpha pathway is expressed in GH4C1 rat pituitary tumors and appears necessary for tumor formation [J]. Endocrinology, 1994;135(1): 416-422.
  • 10[10]Andries M, Tilemans D, Denef C. Modulation of epidermal growth factor receptor binding and action by N-acetyl-TGF alpha (34-43) methyl ester [J]. Peptides, 1994; 15(4): 619-625.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部